Pure Global

Remote Digital Care Effects in Adolescents With Type 1 Diabetes - Trial NCT05421715

Access comprehensive clinical trial information for NCT05421715 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Toulouse and is currently Not yet recruiting. The study focuses on type1diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05421715
Not yet recruiting
other
Trial Details
ClinicalTrials.gov • NCT05421715
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Remote Digital Care Effects in Adolescents With Type 1 Diabetes
Preliminary Study for the Evaluation of Teleduc-diab Additional Remote Digitalcare Effects in Adolescents With Poorly Controled Type 1 Diabetes

Study Focus

type1diabetes

TELEDUC-DIAB

Interventional

other

Sponsor & Location

University Hospital, Toulouse

Timeline & Enrollment

N/A

Oct 01, 2022

Dec 01, 2024

30 participants

Primary Outcome

Evolution of glycemic control hemoglobin (HbA1c) between inclusion and 6 months

Summary

Pilot study to evaluate effects of an experimental additional remote digital care
 (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring
 platform and educative app

ICD-10 Classifications

Type 1 diabetes mellitus
Type 1 diabetes mellitus with unspecified complications
Type 1 diabetes mellitus with other specified complications
Type 1 diabetes mellitus without complications
Type 1 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT05421715

Non-Device Trial